Venus Remedies has received patent from the US patent office for a breakthrough antibiotic product.
The new drug product CSE1034 which is an antibiotic adjuvant entity (AAE), has been found to be effective against a wide range of drug resistant infections including the 'superbugs' like carbapenemase resistant metallobetalactamses (MBL) strains.
The company made this announcement on 12 June 2012.